×

This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.

1

Uncommon Causes of Cardiomegaly : Exploring Rare Cardiac Conditions Leading to Enlarged Heart

Cardiomegaly, characterized by an enlarged heart, is commonly associated with various cardiovascular conditions such as heart failure, coronary artery disease, or hypertension. However, there are instances when the underlying causes of cardiomegaly deviate from the typical cardiovascular pathologies, leading to diagnostic challenges for healthcare providers. This article aims to shed light on uncommon causes of cardiomegaly, delving into rare cardiac conditions that can result in an enlarged heart. By understanding these less frequently encountered conditions, healthcare professionals can enhance their diagnostic capabilities and provide appropriate management for patients with atypical presentations of cardiomegaly.

Uncommon Causes of Cardiomegaly: Exploring Rare Cardiac Conditions Leading to Enlarged Heart 

  1. Infiltrative Cardiomyopathies:

Infiltrative cardiomyopathies represent a group of rare cardiac disorders characterized by the infiltration of abnormal substances into the myocardium. Conditions such as amyloidosis, sarcoidosis, hemochromatosis, or glycogen storage diseases can lead to cardiomegaly due to the deposition of abnormal proteins, iron, or glycogen in the cardiac tissue. These infiltrates disrupt normal cardiac function, resulting in heart enlargement.(1)

  1. Non-compaction Cardiomyopathy:

Non-compaction cardiomyopathy is a rare congenital condition characterized by the failure of the myocardium to properly compact during fetal development. This results in a sponge-like appearance of the myocardium with deep trabeculations and recesses. The enlarged and weakened heart in non-compaction cardiomyopathy can lead to cardiomegaly and increase the risk of heart failure, arrhythmias, and blood clots.(2)

  1. Restrictive Cardiomyopathy:

Restrictive cardiomyopathy is a rare condition characterized by stiffening of the myocardium, impairing its ability to stretch and fill with blood properly. This leads to elevated pressures in the heart chambers and subsequent enlargement. Causes of restrictive cardiomyopathy can include idiopathic or genetic factors, infiltrative diseases, radiation therapy, or certain medications.(3)

  1. Endomyocardial Fibrosis:

Endomyocardial fibrosis is a rare disease characterized by the formation of fibrous tissue within the endocardium (inner lining) of the heart chambers. The fibrosis restricts blood flow, leading to cardiac enlargement. Endomyocardial fibrosis is commonly seen in tropical regions and is associated with parasitic infections, such as schistosomiasis or eosinophilia.(4)

  1. Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC):

ARVC is a rare genetic disorder characterized by the replacement of normal heart muscle tissue with fibrous or fatty tissue, predominantly affecting the right ventricle. The progressive loss of myocardium leads to an enlarged heart and arrhythmias. ARVC is often associated with ventricular arrhythmias and an increased risk of sudden cardiac death.(5)

  1. Takotsubo Syndrome:

Also known as stress cardiomyopathy or “broken heart syndrome,” Takotsubo syndrome is a condition characterized by sudden and temporary weakening of the heart muscle, resulting in ballooning of the left ventricle. While typically triggered by emotional or physical stress, the exact cause of Takotsubo syndrome is not fully understood. The transient enlargement of the heart in this condition can mimic cardiomegaly.(6)

Rare Causes of Cardiomegaly

In addition to the more common causes of cardiomegaly, there are a number of rare conditions that can also lead to an enlarged heart. These conditions include:

Amyloidosis: This is a rare condition that causes abnormal protein deposits to build up in the body, including the heart.

Sarcoidosis: This is a chronic inflammatory disease that can affect many different organs in the body, including the heart.

Hypothyroidism: This is a condition in which the thyroid gland does not produce enough hormones. Low levels of thyroid hormone can lead to a number of heart problems, including cardiomegaly.

Acromegaly: This is a rare condition that is caused by an excess of growth hormone. Acromegaly can lead to a number of heart problems, including cardiomegaly.

Hemochromatosis: This is a condition in which the body absorbs too much iron. Excess iron can build up in the heart and other organs, leading to a number of problems, including cardiomegaly.

Treatment for Rare Causes of Cardiomegaly

The treatment for rare causes of cardiomegaly depends on the underlying condition. In some cases, treatment may include medication, surgery, or a combination of both.

Medication: Medications may be used to treat the underlying condition, such as amyloidosis or sarcoidosis. Medications may also be used to treat the symptoms of cardiomegaly, such as shortness of breath, fatigue, and chest pain.

Surgery: Surgery may be necessary to treat some rare causes of cardiomegaly, such as acromegaly or hemochromatosis. Surgery may be used to remove excess tissue from the heart or to repair damage to the heart.

Prognosis for Rare Causes of Cardiomegaly

The prognosis for rare causes of cardiomegaly varies depending on the underlying condition. In some cases, the condition can be successfully treated and the patient can live a normal life. In other cases, the condition may be progressive and lead to heart failure or death.

Conclusion:

While cardiomegaly is commonly associated with well-known cardiovascular conditions, it is essential for healthcare providers to be aware of the less common causes leading to an enlarged heart. Infiltrative cardiomyopathies, non-compaction cardiomyopathy, restrictive cardiomyopathy, endomyocardial fibrosis, arrhythmogenic right ventricular cardiomyopathy, and Takotsubo syndrome are just a few examples of rare cardiac conditions that can result in cardiomegaly.

Recognizing these uncommon causes of cardiomegaly is crucial for accurate diagnosis and appropriate management. A comprehensive evaluation, including a detailed clinical history, physical examination, and diagnostic investigations, is essential in identifying the underlying cause. Collaboration among healthcare professionals, such as cardiologists, geneticists, and radiologists, is important in unraveling the complexities of these rare conditions.

By expanding our knowledge and understanding of uncommon causes of cardiomegaly, we can provide timely and tailored treatment approaches to improve patient outcomes. Further research and ongoing education are vital in deepening our understanding of these rare cardiac conditions, ultimately enhancing the care and management of patients with atypical presentations of cardiomegaly.

References:

  1. Siddiqi, O. K., Ruberg, F. L. (2018). Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends in cardiovascular medicine, 28(1), 10-21.
  2. Arbustini, E., Favalli, V., Narula, N., Serio, A., Grasso, M. (2016). Left ventricular noncompaction: A distinct genetic cardiomyopathy? Journal of the American College of Cardiology, 68(9), 949-966.
  3. Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Heliö T, Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L, Elliott PM. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013 May;34(19):1448-58. doi: 10.1093/eurheartj/ehs397. Epub 2012 Dec 4. PMID: 23211230.
  4. Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008 Jul 3;359(1):43-9. doi: 10.1056/NEJMoa0708629. PMID: 18596273.
  5. Corrado, D., Basso, C., Judge, D. P. (2017). Arrhythmogenic cardiomyopathy. Circulation research, 121(7), 784-802.
  6. Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076. PMID: 29850871; PMCID: PMC5991216.

Also Read:

Team PainAssist
Team PainAssist
Written, Edited or Reviewed By: Team PainAssist, Pain Assist Inc. This article does not provide medical advice. See disclaimer
Last Modified On:June 9, 2023

Recent Posts

Related Posts